Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 91-100 of 120 for

Edit search filters
  1. A Study to Assess the Safety and Pharmacokinetics of GDC-8264 in Combination With Standard of Care in Participants With Acute Graft-Versus-Host Disease (aGVHD)

    Rochester, MN

  2. A Study of Patients Treated for Wiskott-Aldrich Syndrome Since 1990

    Rochester, MN

  3. A Study to Investigate the Implications of Loss of Gut Microbiota Diversity and Long-term Clinical Outcomes in alloHSCT Recipients

    Jacksonville, FL

  4. A Study of Patients Treated for Chronic Granulomatous Disease Since 1995

    Rochester, MN

  5. A Study to Assess Feasibility and Benefit of a Patient-reported Outcomes Quality of Life Tool for Hematology and Medical Oncology

    Scottsdale/Phoenix, AZ

  6. A Study to Evaluate Clinical Performance of the Aptima® CMV Quant Assay on the Panther® System

    Rochester, MN

  7. Acute Respiratory Distress Syndrome (ARDS) and Acute Respiratory Failure (ARF) Following Hematopoietic Stem Cell Transplantation

    Rochester, MN, Scottsdale/Phoenix, AZ

  8. A Study of Severe Combined Immunodeficiency Disorders

    Rochester, MN

  9. The Impact of Hospital Hospitality Houses (HHH) Programs on the Quality of Life and Mood of Hematopoietic Stem Cell Transplant (HCT) Patients and Their Caregivers

    Rochester, MN

  10. Patient Satisfaction with Pharmacist Video Visits in the Mayo Clinic William J. von Liebig Center for Transplantation and Clinical Regeneration

    Rochester, MN

.

Mayo Clinic Footer